Inflammatix Announces $7.4 Million in Additional BARDA Funding to Advance ViraBac EZ Acute Infection Test
Amount Raised
$7 Million
Round Type
Funding Round
SunnyvaleBiotechnologyDescription
Inflammatix, a pioneering molecular diagnostics company, announced today a contract extension of $7.4 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response, to further develop its point-of-care test and system to diagnose infection by reading the immune system. The contract is part of a BARDA contract worth up to $72 million, if all options are exercised.
Quick answer
Inflammatix raised $7 Million in a Funding Round round, dated October 29, 2020. Inflammatix is based in Sunnyvale, California, United States.
- How much did Inflammatix raise?
- Inflammatix raised $7 Million in a Funding Round round on October 29, 2020.
- What does Inflammatix do?
- Inflammatix is developing an innovative point-of-care instrument platform to be used with a test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response..
- Where is Inflammatix based and how big is it?
- Inflammatix is based in Sunnyvale, California, United States. Fundz records about 87 employees.
- Who are the decision-makers at Inflammatix?
- Fundz holds 1 contact at Inflammatix, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Inflammatix that raised within 45 days of this round, from Fundz verified event records.
- ENvue Medical, Inc. raised $6.6M on December 11, 2020.
- Amplified Sciences, LLC raised $1.1M (Seed) on December 11, 2020.
- Sirnaomics, Inc. raised $89M on December 10, 2020.
- Sight Sciences raised $23M on December 10, 2020.
- Switchback Systems raised $2M (Seed) on December 10, 2020.
- CG Oncology raised $47M (Series D) on December 10, 2020.
Who to call at Inflammatix, and when
A new round usually means Inflammatix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inflammatix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inflammatix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inflammatix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inflammatix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Inflammatix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.